BOARD OF DIRECTORS
Position: Non-executive Vice Chairman
Type: Other External
First appointment: 05/04/06
Last appointment: 27/05/16
Mr. Thomas H. Glanzmann has served as director of Grifols, S.A since April 2006 and as non-executive Vice-Chairman since 1 January 2017. From 2006 until 2011 he was the Chief Executive Officer and President of Gambro AB. Previously Mr. Glanzmann was the CEO and Managing Director of HemoCue AB. Between 1988 and 2004 he held various positions at Baxter Healthcare Corporation: Senior Vice-President and Senior Corporate Officer of Baxter Healthcare Corporation; President of Baxter Bioscience; Chief Executive Officer of Immuno International; and President of the European Biotech Group. Between 1984 and 1988 he worked at Philip Morris becoming country manager for Norway, Denmark and Iceland.
He holds a B.A . degree in Political Science from Dartmouth College, United States, and an M.B.A. from IMD, Lausanne-Switzerland. He also holds a Board of Directors Certification from the UCLA Anderson School of Management, USA.
Mr. Thomas Glanzmann was a Senior Advisor to the Executive Chairman and a Managing Director at The World Economic Forum in Davos from 2004 - 2005 and the Chairman of the Plasma Protein Therapeutics Association (PPTA) between 2000 and 2001.
He serves as a Director on the Board of Alcon, Inc. and is a Healthcare Advisor to Madison Dearborn and Partners. He is a Founder and General Partner of Medical Technology Venture Partners in California, United States.
Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world.
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?